Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 32 | 2023 | 61 | 11.120 |
Why?
|
| Obesity, Morbid | 31 | 2023 | 87 | 9.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2022 | 177 | 4.250 |
Why?
|
| Bariatric Surgery | 11 | 2023 | 45 | 4.040 |
Why?
|
| Weight Loss | 15 | 2022 | 105 | 3.870 |
Why?
|
| Laparoscopy | 21 | 2022 | 170 | 3.090 |
Why?
|
| Insulin Resistance | 6 | 2018 | 49 | 1.940 |
Why?
|
| Obesity | 7 | 2022 | 290 | 1.900 |
Why?
|
| Postoperative Complications | 10 | 2023 | 827 | 1.620 |
Why?
|
| Adipose Tissue | 4 | 2018 | 69 | 1.320 |
Why?
|
| Middle Aged | 43 | 2022 | 8403 | 1.270 |
Why?
|
| Gastrectomy | 5 | 2023 | 26 | 1.220 |
Why?
|
| Gastroesophageal Reflux | 10 | 2007 | 24 | 1.150 |
Why?
|
| Humans | 69 | 2023 | 25692 | 1.140 |
Why?
|
| Female | 47 | 2022 | 14273 | 1.100 |
Why?
|
| Male | 43 | 2022 | 13917 | 1.030 |
Why?
|
| Adult | 32 | 2022 | 7336 | 1.030 |
Why?
|
| Body Mass Index | 8 | 2019 | 419 | 1.010 |
Why?
|
| Insulin | 3 | 2014 | 83 | 0.970 |
Why?
|
| Prospective Studies | 18 | 2022 | 1633 | 0.960 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 140 | 0.910 |
Why?
|
| Bibliometrics | 2 | 2021 | 31 | 0.870 |
Why?
|
| General Surgery | 2 | 2021 | 49 | 0.850 |
Why?
|
| Fundoplication | 8 | 2007 | 20 | 0.850 |
Why?
|
| Caloric Restriction | 2 | 2014 | 16 | 0.840 |
Why?
|
| Biomarkers | 3 | 2020 | 554 | 0.810 |
Why?
|
| Follow-Up Studies | 15 | 2022 | 1689 | 0.800 |
Why?
|
| Digestive System Surgical Procedures | 6 | 2015 | 22 | 0.800 |
Why?
|
| Adiponectin | 2 | 2012 | 10 | 0.790 |
Why?
|
| Omentum | 2 | 2012 | 6 | 0.790 |
Why?
|
| Treatment Outcome | 19 | 2022 | 3231 | 0.780 |
Why?
|
| Esophageal Achalasia | 6 | 2015 | 15 | 0.750 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 27 | 0.730 |
Why?
|
| Weight Gain | 2 | 2021 | 62 | 0.710 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 65 | 0.690 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 41 | 0.670 |
Why?
|
| Mental Disorders | 1 | 2022 | 159 | 0.660 |
Why?
|
| Protein Precursors | 1 | 2019 | 15 | 0.660 |
Why?
|
| Fractures, Bone | 1 | 2020 | 71 | 0.650 |
Why?
|
| Neoplasms | 1 | 2022 | 224 | 0.640 |
Why?
|
| Case-Control Studies | 8 | 2019 | 532 | 0.600 |
Why?
|
| Hydroxybutyrates | 1 | 2018 | 7 | 0.600 |
Why?
|
| Postprandial Period | 3 | 2016 | 7 | 0.590 |
Why?
|
| Retrospective Studies | 13 | 2023 | 3220 | 0.580 |
Why?
|
| Gastroplasty | 4 | 2013 | 22 | 0.550 |
Why?
|
| Vascular Diseases | 1 | 2016 | 40 | 0.520 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2016 | 11 | 0.520 |
Why?
|
| Aged | 20 | 2022 | 8501 | 0.510 |
Why?
|
| Adipocytes | 2 | 2012 | 20 | 0.500 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 340 | 0.490 |
Why?
|
| Peptide YY | 2 | 2011 | 2 | 0.490 |
Why?
|
| Leptin | 2 | 2011 | 20 | 0.490 |
Why?
|
| Quality of Life | 5 | 2007 | 600 | 0.470 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 5 | 0.450 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 60 | 0.430 |
Why?
|
| Time Factors | 5 | 2016 | 1336 | 0.410 |
Why?
|
| Nomograms | 1 | 2012 | 6 | 0.400 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 8 | 0.400 |
Why?
|
| Anastomosis, Roux-en-Y | 3 | 2007 | 5 | 0.390 |
Why?
|
| E2F4 Transcription Factor | 1 | 2011 | 2 | 0.390 |
Why?
|
| Appetite | 1 | 2011 | 3 | 0.390 |
Why?
|
| Cohort Studies | 5 | 2022 | 1781 | 0.390 |
Why?
|
| Blood Glucose | 4 | 2014 | 104 | 0.380 |
Why?
|
| Cell Differentiation | 1 | 2012 | 127 | 0.380 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 37 | 0.380 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 80 | 0.370 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 140 | 0.360 |
Why?
|
| Postoperative Period | 3 | 2019 | 292 | 0.330 |
Why?
|
| Esophagus | 2 | 2007 | 62 | 0.320 |
Why?
|
| Risk Factors | 8 | 2021 | 2224 | 0.300 |
Why?
|
| Bone and Bones | 2 | 2019 | 112 | 0.300 |
Why?
|
| Body Composition | 2 | 2021 | 57 | 0.300 |
Why?
|
| Deglutition Disorders | 2 | 2007 | 32 | 0.290 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2007 | 3 | 0.280 |
Why?
|
| Catheter Ablation | 3 | 2004 | 64 | 0.280 |
Why?
|
| Coronary Disease | 1 | 2007 | 56 | 0.280 |
Why?
|
| Incidence | 2 | 2022 | 731 | 0.270 |
Why?
|
| United States | 5 | 2022 | 1943 | 0.260 |
Why?
|
| Laparotomy | 2 | 2021 | 19 | 0.250 |
Why?
|
| Cholecystitis | 3 | 2023 | 10 | 0.250 |
Why?
|
| Young Adult | 5 | 2016 | 1855 | 0.250 |
Why?
|
| Hypoglycemia | 2 | 2016 | 13 | 0.240 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2015 | 280 | 0.240 |
Why?
|
| Esophageal Neoplasms | 2 | 2005 | 49 | 0.240 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2012 | 10 | 0.230 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 13 | 0.230 |
Why?
|
| Adolescent | 5 | 2016 | 2076 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 86 | 0.220 |
Why?
|
| Absorptiometry, Photon | 2 | 2014 | 73 | 0.220 |
Why?
|
| Transcription Factors | 1 | 2004 | 158 | 0.220 |
Why?
|
| Reoperation | 2 | 2021 | 818 | 0.220 |
Why?
|
| Apoptosis | 1 | 2004 | 177 | 0.220 |
Why?
|
| Preoperative Period | 3 | 2019 | 80 | 0.220 |
Why?
|
| Gallstones | 1 | 2023 | 9 | 0.210 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 132 | 0.210 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 249 | 0.200 |
Why?
|
| Energy Metabolism | 2 | 2021 | 47 | 0.200 |
Why?
|
| Fibronectins | 1 | 2022 | 20 | 0.200 |
Why?
|
| Metabolome | 1 | 2021 | 12 | 0.190 |
Why?
|
| Esophagoscopy | 4 | 2005 | 13 | 0.190 |
Why?
|
| Comorbidity | 2 | 2021 | 457 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 105 | 0.190 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 5 | 0.190 |
Why?
|
| Cells, Cultured | 2 | 2012 | 495 | 0.180 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 209 | 0.180 |
Why?
|
| Hospital Mortality | 1 | 2021 | 131 | 0.180 |
Why?
|
| Linear Models | 2 | 2014 | 231 | 0.170 |
Why?
|
| Medicare | 1 | 2021 | 107 | 0.170 |
Why?
|
| Patient Readmission | 1 | 2021 | 116 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2014 | 618 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 847 | 0.170 |
Why?
|
| Analysis of Variance | 2 | 2019 | 256 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 284 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 311 | 0.160 |
Why?
|
| Bone Density | 1 | 2019 | 133 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 33 | 0.150 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.150 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 3 | 0.150 |
Why?
|
| Kidney | 1 | 2018 | 155 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 178 | 0.140 |
Why?
|
| Prognosis | 3 | 2015 | 739 | 0.140 |
Why?
|
| Gene Expression | 1 | 2017 | 182 | 0.140 |
Why?
|
| Patient Satisfaction | 4 | 2007 | 284 | 0.140 |
Why?
|
| Remission Induction | 1 | 2016 | 80 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2016 | 116 | 0.130 |
Why?
|
| Length of Stay | 1 | 2017 | 300 | 0.130 |
Why?
|
| Recurrence | 1 | 2016 | 275 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2007 | 1077 | 0.120 |
Why?
|
| Gastroscopy | 2 | 2004 | 9 | 0.120 |
Why?
|
| Gastrointestinal Hormones | 1 | 2014 | 1 | 0.120 |
Why?
|
| Amino Acids | 1 | 2014 | 16 | 0.110 |
Why?
|
| Lipids | 1 | 2014 | 50 | 0.110 |
Why?
|
| Biliopancreatic Diversion | 1 | 2013 | 1 | 0.110 |
Why?
|
| Duodenum | 1 | 2013 | 6 | 0.110 |
Why?
|
| Carbon | 1 | 2013 | 8 | 0.110 |
Why?
|
| Choline | 1 | 2013 | 5 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2014 | 185 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2013 | 30 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 19 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 37 | 0.100 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2011 | 1 | 0.100 |
Why?
|
| Ghrelin | 1 | 2011 | 2 | 0.100 |
Why?
|
| Neuropeptide Y | 1 | 2011 | 4 | 0.100 |
Why?
|
| Reference Values | 1 | 2012 | 183 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 89 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 259 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2011 | 16 | 0.100 |
Why?
|
| Fasting | 1 | 2011 | 21 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2012 | 123 | 0.100 |
Why?
|
| Food | 1 | 2011 | 33 | 0.090 |
Why?
|
| Suture Techniques | 3 | 2007 | 136 | 0.090 |
Why?
|
| Chi-Square Distribution | 3 | 2007 | 126 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2012 | 284 | 0.090 |
Why?
|
| Aging | 2 | 2018 | 1429 | 0.090 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 2015 | 35 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 262 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2009 | 25 | 0.080 |
Why?
|
| Medicaid | 1 | 2009 | 29 | 0.080 |
Why?
|
| Esophagogastric Junction | 2 | 2004 | 10 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 19 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 119 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 25 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 30 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 40 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2007 | 57 | 0.070 |
Why?
|
| Tennessee | 1 | 2006 | 7 | 0.070 |
Why?
|
| Operative Time | 2 | 2017 | 83 | 0.060 |
Why?
|
| Markov Chains | 1 | 2006 | 29 | 0.060 |
Why?
|
| Gastroenterostomy | 1 | 2005 | 1 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2006 | 21 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 170 | 0.060 |
Why?
|
| Body Weight | 1 | 2006 | 137 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 36 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2005 | 33 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 46 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2006 | 87 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 124 | 0.060 |
Why?
|
| Endoscopy | 1 | 2007 | 168 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2006 | 75 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 277 | 0.060 |
Why?
|
| Choledocholithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cholecystolithiasis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Diet | 1 | 2006 | 207 | 0.060 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2004 | 3 | 0.060 |
Why?
|
| Logistic Models | 1 | 2005 | 366 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 37 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 79 | 0.060 |
Why?
|
| Laryngitis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Hyperthermia, Induced | 1 | 2004 | 6 | 0.060 |
Why?
|
| Laryngostenosis | 1 | 2004 | 5 | 0.060 |
Why?
|
| Animals | 2 | 2018 | 3510 | 0.060 |
Why?
|
| Calcium | 1 | 2007 | 364 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 221 | 0.060 |
Why?
|
| Motor Activity | 1 | 2006 | 304 | 0.060 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 5 | 0.050 |
Why?
|
| Bile | 2 | 1993 | 5 | 0.050 |
Why?
|
| Abdomen | 1 | 2022 | 8 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 29 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2022 | 25 | 0.050 |
Why?
|
| Standard of Care | 1 | 2021 | 12 | 0.050 |
Why?
|
| Peritoneum | 1 | 2021 | 16 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2021 | 18 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 4459 | 0.050 |
Why?
|
| Equipment Design | 3 | 2006 | 139 | 0.040 |
Why?
|
| Postmenopause | 1 | 2019 | 53 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 33 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 13 | 0.040 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 1997 | 1 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2017 | 140 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2006 | 299 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 45 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 1996 | 1 | 0.030 |
Why?
|
| Sigmoid Diseases | 1 | 1996 | 1 | 0.030 |
Why?
|
| Anemia | 1 | 2017 | 88 | 0.030 |
Why?
|
| Abdominal Abscess | 1 | 1996 | 3 | 0.030 |
Why?
|
| Diverticulitis, Colonic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 136 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 427 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2016 | 12 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 201 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 133 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 716 | 0.030 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 2 | 0.030 |
Why?
|
| Appendectomy | 1 | 2015 | 16 | 0.030 |
Why?
|
| Manometry | 2 | 2005 | 14 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 30 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 1993 | 41 | 0.030 |
Why?
|
| Conversion to Open Surgery | 1 | 2013 | 4 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 199 | 0.020 |
Why?
|
| Learning Curve | 1 | 2012 | 16 | 0.020 |
Why?
|
| Esthetics | 1 | 2012 | 12 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1992 | 19 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 326 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 144 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 1992 | 70 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 170 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1990 | 24 | 0.020 |
Why?
|
| Computers | 1 | 1990 | 18 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 472 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 71 | 0.020 |
Why?
|
| Gastric Acidity Determination | 1 | 2006 | 2 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 93 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2006 | 7 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2006 | 10 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2006 | 104 | 0.020 |
Why?
|
| Marital Status | 1 | 2006 | 7 | 0.020 |
Why?
|
| Peptide Hormones | 1 | 2006 | 3 | 0.020 |
Why?
|
| Energy Intake | 1 | 2006 | 72 | 0.020 |
Why?
|
| Jejunum | 1 | 2005 | 10 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 8 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2005 | 17 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 308 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 37 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2005 | 62 | 0.020 |
Why?
|
| Neuromuscular Agents | 1 | 2005 | 4 | 0.020 |
Why?
|
| Esophageal Stenosis | 1 | 2005 | 3 | 0.020 |
Why?
|
| Botulinum Toxins | 1 | 2005 | 8 | 0.020 |
Why?
|
| Choledochostomy | 1 | 2004 | 1 | 0.010 |
Why?
|
| Common Bile Duct | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cholangiography | 1 | 2004 | 11 | 0.010 |
Why?
|
| Gastroscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophagoscopes | 1 | 2004 | 1 | 0.010 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2004 | 2 | 0.010 |
Why?
|
| Polyvinyls | 1 | 2004 | 2 | 0.010 |
Why?
|
| Polymethyl Methacrylate | 1 | 2004 | 11 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 120 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 646 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 396 | 0.010 |
Why?
|
| Gastrointestinal Transit | 1 | 2003 | 9 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 8 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 443 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 913 | 0.010 |
Why?
|
| Acute Disease | 2 | 1993 | 187 | 0.010 |
Why?
|
| Colostomy | 1 | 1996 | 2 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 30 | 0.010 |
Why?
|
| Drainage | 1 | 1996 | 43 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1997 | 112 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 574 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1993 | 9 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1992 | 6 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1992 | 9 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1990 | 7 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1990 | 16 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1992 | 403 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1990 | 341 | 0.010 |
Why?
|